CoChat

CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment

Open access
Kim, Ji-Young, Lee, Hwa-Yong, Park, Kwan-Kyu, Choi, Yang-Kyu, Nam, Jeong-Seok, Hong, In-Sun · 2016 · Oncotarget
Cited by 74

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

// Ji-Young Kim 1, 2, * , Hwa-Yong Lee 3, * , Kwan-Kyu Park 4 , Yang-Kyu Choi 2 , Jeong-Seok Nam 5 , In-Sun Hong 6, 7 1 Center of Animal Care and Use, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Republic of Korea 2 Department of Laboratory Animal Medicine, College of Veterinary Medicine, Konkuk University, Seoul, Korea 3 The Faculty of Liberal Arts, Jungwon University, Chungbuk, Republic of Korea 4 Department of Pathology, College of Medicine, Catholic University of Daegu, Daegu, South Korea 5 School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea 6 Laboratory of Stem Cell Research, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, South Korea 7 Department of Molecular Medicine, School of Medicine, Gachon University, Incheon, Republic of Korea * These authors have contributed equally to this work Correspondence to: Jeong-Seok Nam, e-mail: namjs0206@gmail.com In-Sun Hong, e-mail: hongstem@gachon.ac.kr Keywords: CWP232228, cancer stem cells, Wnt/β-catenin signaling, CD133, ALDH Received: September 11, 2015 Accepted: January 16, 2016 Published: March 07, 2016 ABSTRACT Liver cancer stem cells (CSCs) are resistant to conventional chemotherapy and radiation, which may destroy tumor masses, but not all liver CSCs contribute to tumor initiation, metastasis, and relapse. In the present study, we showed that liver CSCs with elevated Wnt/β-catenin signaling possess much greater self-renewal and clonogenic potential. We further documented that the increased clonogenic potential of liver CSCs is highly associated with changes in Wnt/β-catenin signaling and that Wnt/β-catenin signaling activity is positively correlated with CD133 expression and aldehyde dehydrogenase (ALDH) enzymatic activity. Notably, the small molecule inhibitor CWP232228, which antagonizes the binding of β-catenin to TCF in the nucleus, inhibits Wnt/β-catenin signaling and depletes CD133 + /ALDH + liver CSCs, thus ultimately diminishing the self-renewal capacity of CSCs and decreasing tumorigenicity in vitro and in vivo . Taken together, our findings suggest that CWP232228 acts as a candidate therapeutic agent for liver cancer by preferentially targeting liver CSCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.7954

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Kim, J.-Y., Lee, H.-Y., Park, K.-K., Choi, Y.-K., Nam, J.-S., & Hong, I.-S.
Venue
Oncotarget
Published
2016-03-07
Volume
7
Issue
15
Pages
20395-20409
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2294465717
Cited by
74
References
3
FWCI
4.51
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.